Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Current Oncology (Toronto, Ont.)|November 24, 2023
Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer XenograftsPatrick B Thomas, Saeid Alinezhad, Andre Joshi, et al.
Immunology and Cell Biology|October 30, 2024
Altered immunophenotypic expression in the peripheral bladder cancer immune landscapeNathan J Mackenzie, Kate Zimmermann, Clarissa Nicholls, et al.
Endocrine|November 4, 2018
Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys<sup>3</sup>]-GHRP-6Michelle L Maugham, Inge Seim, Patrick B Thomas, et al.
Clinical & Translational Immunology|July 5, 2022
Modelling the tumor immune microenvironment for precision immunotherapyNathan J Mackenzie, Clarissa Nicholls, Abby R Templeton, et al.
Plos One|November 21, 2018
No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunctionMichelle L Maugham, Inge Seim, Patrick B Thomas, et al.
International Journal of Oncology|June 1, 2013
Identification of a long non-coding RNA gene, growth hormone secretagogue receptor opposite strand, which stimulates cell migration in non-small cell lung cancer cell linesEliza J Whiteside, Inge Seim, Jana P Pauli, et al.
Peerj|February 15, 2021
The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotypePatrick B Thomas, Penny Jeffery, Manuel D Gahete, et al.
Scientific Reports|March 30, 2017
Insights from engraftable immunodeficient mouse models of hyperinsulinaemiaMichelle L Maugham, Patrick B Thomas, Gabrielle J Crisp, et al.
Endocrine|January 22, 2016
Multi-species sequence comparison reveals conservation of ghrelin gene-derived splice variants encoding a truncated ghrelin peptideInge Seim, Penny L Jeffery, Patrick B Thomas, et al.
Frontiers in Oncology|January 6, 2022
Patient-Derived Explants as a Precision Medicine Patient-Proximal Testing Platform Informing Cancer ManagementAbby R Templeton, Penny L Jeffery, Patrick B Thomas, et al.
Pageof 3